schliessen

Filtern

 

Bibliotheken

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.(antineutrophil cytoplasm antibody)(Report)

Journal Title: Annals of the Rheumatic Diseases June, 2015, Vol.74(6), p.1178(5)
Main Author: Jones, Rachel B
Other Authors: Furuta, Shunsuke , Tervaert, Jan Willem Cohen , Hauser, Thomas , Luqmani, Raashid , Morgan, Matthew D , Peh, Chen Au , Savage, Caroline O , Segelmark, Marten , Tesar, Vladimir , Paassen, Pieter Van , Walsh, Michael , Westman, Kerstin , Jayne, David Rw
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Cengage Learning, Inc.
ID: ISSN: 0003-4967
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: gale_hrca414937729
title: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.(antineutrophil cytoplasm antibody)(Report)
format: Article
creator:
  • Jones, Rachel B
  • Furuta, Shunsuke
  • Tervaert, Jan Willem Cohen
  • Hauser, Thomas
  • Luqmani, Raashid
  • Morgan, Matthew D
  • Peh, Chen Au
  • Savage, Caroline O
  • Segelmark, Marten
  • Tesar, Vladimir
  • Paassen, Pieter Van
  • Walsh, Michael
  • Westman, Kerstin
  • Jayne, David Rw
subjects:
  • Clinical Trials -- Usage
  • Cyclophosphamide -- Dosage And Administration
  • Cyclophosphamide -- Comparative Analysis
  • Rituximab -- Dosage And Administration
  • Rituximab -- Comparative Analysis
  • Vasculitis -- Risk Factors
  • Vasculitis -- Care And Treatment
  • Vasculitis -- Patient Outcomes
ispartof: Annals of the Rheumatic Diseases, June, 2015, Vol.74(6), p.1178(5)
description:
language: English
source: Cengage Learning, Inc.
identifier: ISSN: 0003-4967
fulltext: fulltext
issn:
  • 0003-4967
  • 00034967
url: Link


@attributes
ID1689177731
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid414937729
sourceidgale_hrca
recordidTN_gale_hrca414937729
sourceformatXML
sourcesystemPC
galeid414937729
display
typearticle
titleRituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.(antineutrophil cytoplasm antibody)(Report)
creatorJones, Rachel B ; Furuta, Shunsuke ; Tervaert, Jan Willem Cohen ; Hauser, Thomas ; Luqmani, Raashid ; Morgan, Matthew D ; Peh, Chen Au ; Savage, Caroline O ; Segelmark, Marten ; Tesar, Vladimir ; Paassen, Pieter Van ; Walsh, Michael ; Westman, Kerstin ; Jayne, David Rw
ispartofAnnals of the Rheumatic Diseases, June, 2015, Vol.74(6), p.1178(5)
identifierISSN: 0003-4967
subjectClinical Trials -- Usage ; Cyclophosphamide -- Dosage And Administration ; Cyclophosphamide -- Comparative Analysis ; Rituximab -- Dosage And Administration ; Rituximab -- Comparative Analysis ; Vasculitis -- Risk Factors ; Vasculitis -- Care And Treatment ; Vasculitis -- Patient Outcomes
languageEnglish
sourceCengage Learning, Inc.
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Jones, Rachel B
1Furuta, Shunsuke
2Tervaert, Jan Willem Cohen
3Hauser, Thomas
4Luqmani, Raashid
5Morgan, Matthew D
6Peh, Chen Au
7Savage, Caroline O
8Segelmark, Marten
9Tesar, Vladimir
10Paassen, Pieter van
11Walsh, Michael
12Westman, Kerstin
13Jayne, David RW
titleRituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.(antineutrophil cytoplasm antibody)(Report)
subject
0Clinical trials--Usage
1Cyclophosphamide--Dosage and administration
2Cyclophosphamide--Comparative analysis
3Rituximab--Dosage and administration
4Rituximab--Comparative analysis
5Vasculitis--Risk factors
6Vasculitis--Care and treatment
7Vasculitis--Patient outcomes
general
0English
1British Medical Association
2Cengage Learning, Inc.
sourceidgale_hrca
recordidgale_hrca414937729
issn
00003-4967
100034967
rsrctypearticle
creationdate2015
recordtypearticle
addtitleAnnals of the Rheumatic Diseases
searchscopegale_hrca
scopegale_hrca
sort
titleRituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.(antineutrophil cytoplasm antibody)(Report)
authorJones, Rachel B ; Furuta, Shunsuke ; Tervaert, Jan Willem Cohen ; Hauser, Thomas ; Luqmani, Raashid ; Morgan, Matthew D ; Peh, Chen Au ; Savage, Caroline O ; Segelmark, Marten ; Tesar, Vladimir ; Paassen, Pieter Van ; Walsh, Michael ; Westman, Kerstin ; Jayne, David Rw
creationdate20150601
facets
frbrgroupid9013053710153072730
frbrtype6
languageeng
creationdate2015
topic
0Clinical Trials–Usage
1Cyclophosphamide–Dosage And Administration
2Cyclophosphamide–Comparative Analysis
3Rituximab–Dosage And Administration
4Rituximab–Comparative Analysis
5Vasculitis–Risk Factors
6Vasculitis–Care And Treatment
7Vasculitis–Patient Outcomes
collectionHealth Reference Center Academic (Gale)
prefilterarticles
rsrctypearticles
creatorcontrib
0Jones, Rachel B
1Furuta, Shunsuke
2Tervaert, Jan Willem Cohen
3Hauser, Thomas
4Luqmani, Raashid
5Morgan, Matthew D
6Peh, Chen Au
7Savage, Caroline O
8Segelmark, Marten
9Tesar, Vladimir
10Paassen, Pieter Van
11Walsh, Michael
12Westman, Kerstin
13Jayne, David Rw
jtitleAnnals of the Rheumatic Diseases
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Jones, Rachel B
1Furuta, Shunsuke
2Tervaert, Jan Willem Cohen
3Hauser, Thomas
4Luqmani, Raashid
5Morgan, Matthew D
6Peh, Chen Au
7Savage, Caroline O
8Segelmark, Marten
9Tesar, Vladimir
10Paassen, Pieter van
11Walsh, Michael
12Westman, Kerstin
13Jayne, David RW
atitleRituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
jtitleAnnals of the Rheumatic Diseases
risdate20150601
volume74
issue6
spage1178
issn0003-4967
genrearticle
ristypeJOUR
pubBritish Medical Association
lad01gale_hrca
date2015-06-01